{
    "2019-10-22": [
        [
            {
                "time": "",
                "original_text": "【民生医药|周报】10/28：三季报行情步入尾声，持续看好创新药及其产业链",
                "features": {
                    "keywords": [
                        "三季报",
                        "创新药",
                        "产业链"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报: Q3血制品批签发数据回暖, 结构趋于多样",
                "features": {
                    "keywords": [
                        "医药生物",
                        "Q3",
                        "血制品",
                        "批签发",
                        "数据回暖"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}